Mercury Laboratories Limited
BSE: MERCURYLAB
Prev Close
885
Open Price
900
Volume
241
Today Low / High
843.95 / 900
52 WK Low / High
736 / 976
Range
802 - 886
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 843.95, reflecting a change of -41.05 (-4.63842%). The expected target range on the BSE is 802 - 886. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Mercury Laboratories Limited Graph
Mercury Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Mercury Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 843.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 843.95 | 852.39 | 767.15 - 937.63 |
| 860.83 | 688.66 - 1,032.99 | ||
| 869.27 | 608.49 - 1,130.05 | ||
| Bearish Scenario | 843.95 | 835.51 | 751.96 - 919.06 |
| 827.07 | 661.66 - 992.49 | ||
| 818.63 | 573.04 - 1,064.22 |
Overview of Mercury Laboratories Limited
ISIN
INE947G01011
Industry
Medical - Pharmaceuticals
Vol.Avg
261
Market Cap
1,023,600,000
Last Dividend
7
Official Website
IPO Date
2015-02-25
DCF Diff
632.01
DCF
221
Financial Ratios Every Investor Needs
Stock Dividend of MERCURYLAB
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-06 | August 06, 25 | 3.5 | 3.5 | 2025-08-06 | 2025-09-11 | |
| 2024-09-20 | September 20, 24 | 3.5 | 3.5 | 2024-09-20 | 2024-10-26 | |
| 2023-09-20 | September 20, 23 | 3.5 | 3.5 | 2023-09-20 | 2023-10-27 | |
| 2022-09-19 | September 19, 22 | 3.5 | 3.5 | 2022-09-20 | 2022-10-27 | |
| 2021-09-20 | September 20, 21 | 2 | 2 | 2021-09-21 | 2021-10-28 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 75.10 Cr | 28.92 Cr | 46.19 Cr | 0.6150 | 0.00 Cr | 0.00 Cr | 29.34 Cr | 3.14 Cr | 26.21 | 8.09 Cr | 0.0419 |
| 2024-03-31 | 75.56 Cr | 30.54 Cr | 45.02 Cr | 0.5958 | 0.02 Cr | 1.60 Cr | 7.66 Cr | 5.65 Cr | 47.12 | 10.12 Cr | 0.0748 |
| 2023-03-31 | 75.33 Cr | 30.42 Cr | 44.92 Cr | 0.5962 | 0.01 Cr | 0.00 Cr | 6.26 Cr | 5.58 Cr | 46.49 | 10.29 Cr | 0.0741 |
| 2022-03-31 | 57.92 Cr | 23.66 Cr | 34.26 Cr | 0.5915 | 0.02 Cr | 0.89 Cr | 4.86 Cr | 3.56 Cr | 29.68 | 7.93 Cr | 0.0615 |
| 2021-03-31 | 68.60 Cr | 45.75 Cr | 22.85 Cr | 0.3331 | 0.00 Cr | 1.12 Cr | 8.30 Cr | 5.34 Cr | 44.48 | 10.47 Cr | 0.0778 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.19 Cr | 74.24 Cr | 20.67 Cr | 53.5692 Cr | 5.45 Cr | 3.26 Cr | 7.21 Cr | 33.93 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 15.0760 Cr |
| 2024-03-31 | 3.43 Cr | 67.96 Cr | 17.12 Cr | 50.8385 Cr | 5.55 Cr | 2.13 Cr | 6.21 Cr | 27.82 Cr | 0.00 Cr | 0.00 Cr | -4.79 Cr | 12.9438 Cr |
| 2023-03-31 | 3.71 Cr | 67.58 Cr | 21.95 Cr | 45.6289 Cr | 5.83 Cr | 2.13 Cr | 6.90 Cr | 24.35 Cr | 0.40 Cr | 0.00 Cr | 0.01 Cr | 16.4282 Cr |
| 2022-03-31 | 4.11 Cr | 63.22 Cr | 22.88 Cr | 40.3408 Cr | 5.99 Cr | 1.87 Cr | 6.78 Cr | 25.76 Cr | 1.18 Cr | 1.54 Cr | 0.01 Cr | 13.6317 Cr |
| 2021-03-31 | 3.03 Cr | 65.37 Cr | 28.48 Cr | 36.8946 Cr | 7.10 Cr | 4.07 Cr | 5.16 Cr | 26.27 Cr | 0.48 Cr | 1.27 Cr | 0.01 Cr | 18.8337 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.0011 Cr | -9.0399 Cr | -0.9945 Cr | -5.0388 Cr | -6.0333 Cr | 2.1932 Cr | -9.0399 Cr | 3.1449 Cr | 1.4771 Cr | -0.4200 Cr | -1.0002 Cr |
| 2024-03-31 | 7.8684 Cr | -6.2717 Cr | -0.6853 Cr | 1.9533 Cr | 0.9114 Cr | 8.2265 Cr | -6.2717 Cr | 5.6542 Cr | 0.1315 Cr | -0.4200 Cr | 0.6952 Cr |
| 2023-03-31 | 2.4524 Cr | -1.0568 Cr | -1.0128 Cr | 1.3956 Cr | 0.3828 Cr | 7.3151 Cr | -1.0568 Cr | 7.4446 Cr | 0.2228 Cr | -0.4200 Cr | -0.1223 Cr |
| 2022-03-31 | 5.1889 Cr | -1.8920 Cr | -1.2307 Cr | 3.2744 Cr | 2.0662 Cr | 6.9323 Cr | -1.9145 Cr | 5.0311 Cr | -1.2110 Cr | -0.2400 Cr | -1.6211 Cr |
| 2021-03-31 | 8.2138 Cr | -4.6193 Cr | -1.2352 Cr | 3.5945 Cr | 2.3593 Cr | 4.8661 Cr | -4.6193 Cr | 7.9090 Cr | -0.0862 Cr | -0.4200 Cr | 0.3493 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 20.84 Cr | 8.05 Cr | 12.79 Cr | 0.6137 | 8.43 Cr | 1.11 Cr | 9.25 | 2.30 Cr | 0.0533 |
| 2024-12-31 | 19.57 Cr | 7.56 Cr | 12.01 Cr | 0.6138 | 1.24 Cr | 1.19 Cr | 9.94 | 2.51 Cr | 0.0609 |
| 2024-09-30 | 18.19 Cr | 6.81 Cr | 11.38 Cr | 0.6257 | 0.60 Cr | 0.50 Cr | 4.17 | 1.52 Cr | 0.0275 |
| 2024-06-30 | 16.68 Cr | 11.04 Cr | 5.64 Cr | 0.3381 | 0.91 Cr | 0.34 Cr | 2.85 | 1.76 Cr | 0.0205 |
| 2024-03-31 | 17.37 Cr | 10.31 Cr | 7.06 Cr | 0.4065 | 1.94 Cr | 1.91 Cr | 15.92 | 3.06 Cr | 0.1100 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.19 Cr | 0.00 Cr | 2.19 Cr | 25.74 Cr | 7.21 Cr | 40.08 Cr | 33.93 Cr | 74.24 Cr | 20.67 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 2.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -51.70 Cr |
| 2024-09-30 | 0.89 Cr | 2.03 Cr | 2.92 Cr | 0.00 Cr | 6.13 Cr | 36.73 Cr | 32.40 Cr | 69.43 Cr | 17.73 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 8.23 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -50.84 Cr |
| 2024-03-31 | 3.43 Cr | 4.80 Cr | 8.23 Cr | 21.94 Cr | 6.21 Cr | 39.84 Cr | 27.82 Cr | 67.96 Cr | 17.12 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 1.19 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 1.91 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1957
Gender: female
Year Born:
Gender: male
Year Born: 1969
Gender: female
Year Born:
Gender: male
Year Born: 1971
Gender: male
Year Born: 1990
Gender: male
Year Born: 1952
Gender: male
Year Born:
Gender: male
Year Born: 1984
FAQs about Mercury Laboratories Limited
The CEO is Rajendra Ramanlal Shah.
The current price is ₹853.00.
The range is ₹736-950.
The market capitalization is ₹102.36 crores.
The dividend yield is 0.82%.
The P/E ratio is 32.55.
The company operates in the Healthcare sector.
Overview of Mercury Laboratories Limited (ISIN: INE947G01011) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹102.36 crores and an average daily volume of 261 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹7.